The registered shares of Idorsia Ltd were listed on the SIX Swiss Exchange on June 16, 2017 (symbol: IDIA). Following the transfer of Actelion’s drug discovery and early-stage clinical pipeline business to Idorsia, registered Idorsia shares held by Actelion have been distributed to Actelion shareholders by way of a dividend in kind.
Stock information
Idorsia is more than a startup: we have an experienced team and a full pipeline
Andrew Weiss, Head of IR&CC
Stock overview
Get an overview of the key share data, major shareholders, the shareholder structure, how to buy stock and how to register shares.
Stock chart tool
Monitor Idorsia's performance on the SIX Swiss Exchange, compare to other indicies or download the historical share prices.
Covering analysts
Several financial institutions are covering Idorsia.
Consensus estimate
Idorsia uses Vara Research GmbH, an independent data research company, to reach out to covering analysts and compile the consensus estimates.